These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16822790)

  • 21. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?
    Seybert AL; Coons JC; Zerumsky K
    Pharmacotherapy; 2006 Feb; 26(2):229-41. PubMed ID: 16466327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
    John TE; Hallisey RK
    Pharmacotherapy; 2005 Oct; 25(10):1383-8. PubMed ID: 16185183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia type II: a serious hazard in preemptive renal transplantation: a case report.
    Dracopoulos S; Vougas V; Kassimatis TI; Theodoridis T; Ali ME; Apostolou T
    Transplant Proc; 2007 Dec; 39(10):3481-4. PubMed ID: 18089414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia.
    Bauer M; Koster A; Pasic M; Weng Y; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):191-2. PubMed ID: 10384203
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Pinto DS; Sperling RT; Tu TM; Cohen DJ; Carrozza JP
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):65-8. PubMed ID: 12508198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.
    Reilly MP; Weiss R; Askenase A; Tuite C; Soulen M; Mohler ER
    Vasc Med; 2000; 5(4):239-42. PubMed ID: 11213236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An anesthesia provider's perspective of heparin-induced thrombocytopenia.
    Woodyard DN
    AANA J; 2005 Apr; 73(2):115-9. PubMed ID: 15835831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports.
    Manfredi JA; Wall RP; Sane DC; Braden GA
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):468-72. PubMed ID: 11285599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin induced thrombocytopenia management with bivalirudin.
    Meera R; Rachel D; Ramakrishnapillai V; Vijayaraghavan G
    Indian Heart J; 2007; 59(4):354-5. PubMed ID: 19126942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.
    Nikolsky E; Dangas GD
    Semin Thromb Hemost; 2004 Jun; 30(3):305-14. PubMed ID: 15282653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia.
    Clayton SB; Acsell JR; Crumbley AJ; Uber WE
    Ann Thorac Surg; 2004 Dec; 78(6):2167-9. PubMed ID: 15561064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of heparin-induced thrombocytopenia in a patient on hemodialysis complicated with thrombosis in the extracorporeal circuit].
    César JM; Candela A; Tenorio MT; Chinea A; Sáiz R; Liaño F
    Nefrologia; 2008; 28(4):462-3. PubMed ID: 18662159
    [No Abstract]   [Full Text] [Related]  

  • 34. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia.
    Badger NO; Butler K; Hallman LC
    Pharmacotherapy; 2004 Dec; 24(12):1800-3. PubMed ID: 15585446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
    Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
    Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia.
    Greinacher A
    Semin Thromb Hemost; 2004 Jun; 30(3):315-27. PubMed ID: 15282654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
    Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
    J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulation with r-hirudin in a patient with acute renal failure and heparin-induced thrombocytopenia.
    Steuer S; Boogen C; Plum J; Deppe C; Reinauer H; Grabensee B
    Nephrol Dial Transplant; 1999; 14 Suppl 4():45-7. PubMed ID: 10463215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.